Design of cationic lipid nanoparticles for ocular delivery: Development, characterization and cytotoxicity

Araujo, 2009, Nanomedicines for ocular NSAIDs: safety on drug delivery, Nanomedicine, 5, 394, 10.1016/j.nano.2009.02.003 Araújo, 2009, Effect of polymer viscosity on physicochemical properties and ocular tolerance of FB-loaded PLGA nanospheres, Colloids Surf. B, 72, 48, 10.1016/j.colsurfb.2009.03.028 Bhatta, 2012, Mucoadhesive nanoparticles for prolonged ocular delivery of natamycin: in vitro and pharmacokinetics studies, Int. J. Pharm., 432, 105, 10.1016/j.ijpharm.2012.04.060 Bunjes, 2007, Characterization of lipid nanoparticles by differential scanning calorimetry, X-ray and neutron scattering, Adv. Drug Delivery Rev., 59, 379, 10.1016/j.addr.2007.04.013 Celia, 2009, Turbiscan lab expert analysis of the stability of ethosomes and ultradeformable liposomes containing a bilayer fluidizing agent, Colloids Surf. B, 72, 155, 10.1016/j.colsurfb.2009.03.007 del Pozo-Rodriguez, 2013, Lipid nanoparticles as drug/gene delivery systems to the retina, J. Ocul. Pharmacol. Ther., 29, 173, 10.1089/jop.2012.0128 Diebold, 2010, Applications of nanoparticles in ophthalmology, Prog. Retin. Eye Res., 29, 596, 10.1016/j.preteyeres.2010.08.002 Doktorovova, 2011, Cationic solid lipid nanoparticles (cSLN): structure, stability and DNA binding capacity correlation studies, Int. J. Pharm., 420, 341, 10.1016/j.ijpharm.2011.08.042 Fangueiro, 2012, Experimental factorial design applied to mucoadhesive lipid nanoparticles via multiple emulsion process, Colloids Surf. B, 100, 84, 10.1016/j.colsurfb.2012.04.014 Fangueiro, 2013, A novel lipid nanocarrier for insulin delivery: production, characterization and toxicity testing, Pharm. Dev. Technol., 18, 545, 10.3109/10837450.2011.591804 Fiume, 2001, Final report on the safety assessment of lecithin and hydrogenated lecithin, Int. J. Toxicol., 20, 21, 10.1080/109158101750300937 Fresta, 1999, Characterization and in-vivo ocular absorption of liposome-encapsulated acyclovir, J. Pharm. Pharmacol., 51, 565, 10.1211/0022357991772664 Gallarate, 2009, Preparation of solid lipid nanoparticles from W/O/W emulsions: preliminary studies on insulin encapsulation, J. Microencapsul., 26, 394, 10.1080/02652040802390156 García-Fuentes, 2003, Design of lipid nanoparticles for the oral delivery of hydrophilic macromolecules, Colloids Surf. B, 27, 159, 10.1016/S0927-7765(02)00053-X Giannavola, 2003, Influence of preparation conditions on acyclovir-loaded poly-d,l-lactic acid nanospheres and effect of PEG coating on ocular drug bioavailability, Pharm. Res., 20, 584, 10.1023/A:1023290514575 Gonzalez-Mira, 2010, Design and ocular tolerance of flurbiprofen loaded ultrasound-engineered NLC, Colloids Surf. B, 81, 412, 10.1016/j.colsurfb.2010.07.029 Gonzalez-Mira, 2011, Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery, Nanotechnology, 22, 045101, 10.1088/0957-4484/22/4/045101 Gonzalez, 2001, Evaluation of hepatic subcellular fractions for Alamar blue and MTT reductase activity, Toxicol. In Vitro, 15, 257, 10.1016/S0887-2333(01)00014-5 Hamid, 2004, Comparison of alamar blue and MTT assays for high through-put screening, Toxicol. In Vitro, 18, 703, 10.1016/j.tiv.2004.03.012 Han, 2008, Effect of surfactants on the formation and characterization of a new type of colloidal drug delivery system: nanostructured lipid carriers, Colloids Surf. A, 315, 210, 10.1016/j.colsurfa.2007.08.005 Kawaguchi, 2008, Physicochemical properties of structured phosphatidylcholine in drug carrier lipid emulsions for drug delivery systems, Colloids Surf. B, 62, 130, 10.1016/j.colsurfb.2007.09.027 Lallemand, 2012, Successfully improving ocular drug delivery using the cationic nanoemulsion, novasorb, J. Drug Deliv., 604204 Liu, 2011, Turbiscan Lab® Expert analysis of the biological demulsification of a water-in-oil emulsion by two biodemulsifiers, J. Hazard. Mater., 190, 214, 10.1016/j.jhazmat.2011.03.028 Marianecci, 2010, Non-ionic surfactant vesicles in pulmonary glucocorticoid delivery: characterization and interaction with human lung fibroblasts, J. Control. Release, 147, 127, 10.1016/j.jconrel.2010.06.022 Metin, 2005, Crystallization of fats and oils Pignatello, 2011, Nanotechnology in ophthalmic drug delivery: a survey of recent developments and patenting activity, Recent Patents Nanomed., 1, 42, 10.2174/1877912311101010042 Schubert, 2006, Structural investigations on lipid nanoparticles containing high amounts of lecithin, Eur. J. Pharm. Sci., 27, 226, 10.1016/j.ejps.2005.10.004 Schubert, 2003, Solvent injection as a new approach for manufacturing lipid nanoparticles – evaluation of the method and process parameters, Eur. J. Pharm. Sci., 55, 125 Severino, 2012, Current state-of-art and new trends on lipid nanoparticles (SLN and NLC) for oral drug delivery, J. Drug Deliv., 10.1155/2012/750891 Shekunov, 2007, Particle size analysis in pharmaceutics: principles, methods and applications, Pharm Res., 24, 203, 10.1007/s11095-006-9146-7 Souto, 2010, Feasibility of lipid nanoparticles for ocular delivery of anti-inflammatory drugs, Curr. Eye Res., 35, 537, 10.3109/02713681003760168 Sultana, 2011, Nanotechnology in ocular delivery: current and future directions, Drugs Today (Barc), 47, 441, 10.1358/dot.2011.47.6.1549023 Thoma, 1983, Thermoanalytischer Nachweis der Polymorphie der Suppositoriengrundlage Hartfett, Pharm. Ind., 45, 990 Trotta, 2002, Stability of drug-carrier emulsions containing phosphatidylcholine mixtures, Eur. J. Pharm. Biopharm., 53, 203, 10.1016/S0939-6411(01)00230-2 Vega, 2008, PLGA nanospheres for the ocular delivery of flurbiprofen: drug release and interactions, J. Pharm. Sci., 97, 5306, 10.1002/jps.21383 Ying, 2013, Drug delivery to the ocular posterior segment using lipid emulsion via eye drop administration: effect of emulsion formulations and surface modification, Int. J. Pharm., 453, 329, 10.1016/j.ijpharm.2013.06.024 Zimmer, 1995, Microspheres and nanoparticles used in ocular delivery systems, Adv. Drug Delivery Rev., 16, 61, 10.1016/0169-409X(95)00017-2